Indiana Patent of the Month – June 2024
On Target Laboratories, LLC has pioneered a groundbreaking advancement in cancer treatment with their innovative composition utilizing pafolacianine. This novel compound is designed to enhance the visualization of malignant lesions during surgical procedures, particularly for cancers such as ovarian and lung cancers.
Traditional cancer surgeries often face challenges in identifying and completely removing cancerous tissues. On Target Laboratories’ composition addresses this critical need by leveraging pafolacianine, which binds selectively to folate receptors commonly overexpressed in cancer cells. Upon administration, the pafolacianine emits fluorescence when exposed to near-infrared light, providing surgeons with real-time, precise visualization of cancerous lesions.
The process begins with the intravenous administration of the composition, which includes specific concentrations of pafolacianine, sodium chloride, and phosphate buffers to maintain stability and efficacy. This solution, adjusted to a pH between 7.1 to 7.8, ensures optimal conditions for both administration and subsequent fluorescence detection.
During surgery, the surgeon illuminates the suspected cancerous areas with a suitable light source, causing the pafolacianine-bound lesions to fluoresce distinctly. This fluorescence aids in accurately delineating cancerous tissues from healthy ones, facilitating more precise surgical resection. Such targeted visualization not only improves the thoroughness of cancer removal but also reduces the likelihood of leaving residual cancer cells behind.
The method supports various surgical approaches, including both manual and robotic-assisted techniques, enhancing versatility in clinical applications. The integration of advanced imaging systems further refines the procedure, enabling detailed monitoring and verification of cancerous tissue margins.
On Target Laboratories’ commitment to advancing cancer treatment through innovation is evident in their development of this composition. By improving the efficacy of cancer surgeries through enhanced visualization, they aim to improve patient outcomes and quality of life. This invention stands as a testament to the power of research and development in transforming medical practice and patient care in oncology.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
